HUL Declares Interim Dividend of ₹19/Share; Q2FY27 Turnover at ₹18,071 Cr
Hindustan Unilever Limited reported a turnover of ₹18,071 crore for Q2FY27, up 15% YoY, with 7% volume growth. The company declared an interim dividend of ₹19 per share. EBITDA grew 8% to ₹4,089 crore, and PAT (before exceptional items) rose 9% to ₹2,795 crore.
The announcement includes financial results for the quarter and half-year, along with a significant interim dividend declaration. These are material events for investors, impacting stock valuation and investor sentiment.
The company reported strong sales growth, robust volume growth, and an increase in EBITDA and PAT before exceptional items. The declaration of an interim dividend also indicates financial health and commitment to shareholder returns.
Hindustan Unilever Limited (HUL) announced its Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026. The Board of Directors declared an interim dividend of ₹19 per equity share for the financial year ending March 31, 2027. The record date for this dividend is November 12, 2026, with the payment scheduled for November 25, 2026.
The company reported a Turnover of ₹18,071 crores for the quarter ended September 30, 2026, marking a 15% increase year-on-year. Underlying Volume Growth was strong at 7%, contributing to the highest Underlying Sales Growth in the last 14 quarters. EBITDA grew by 8% year-on-year to ₹4,089 crores, with an EBITDA Margin of 22.6%. Profit After Tax before exceptional items grew by 9% year-on-year to ₹2,795 crores. Reported Profit After Tax was flat at ₹2,796 crores due to one-off tax-related gains in the previous year.
For the first half of the financial year, HUL recorded a Turnover of ₹35,255 crores with an Underlying Sales Growth of 12% and Underlying Volume Growth of 6%. EBITDA grew by 8% and PAT (before exceptional items) grew by 9% year-on-year.
The company also provided segment-wise highlights. Home Care delivered 22% USG driven by double-digit UVG. Beauty & Wellbeing recorded 16% USG driven by double-digit UVG. Personal Care reported 9% USG, with Skin Cleansing delivering double-digit USG. Foods achieved 9% USG, led by double-digit USG in Lifestyle Nutrition and Packaged Foods.
Priya Nair, CEO and Managing Director, commented on the results, stating, "In September quarter, we delivered 15% Underlying Sales Growth, our highest in the last 14 quarters, with Turnover of ₹18,071 crores. Underlying Volume Growth was strong at 7% reflecting sustained momentum driven by our focus on crafting desirable brands and strengthening future-fit Go-to-Market. The Indian economy remains resilient, with healthy macro indicators supporting a positive consumption environment. We continue to invest in building long-term capabilities and remain anchored to the ‘Winning in New India’ strategy of delivering competitive, volume-led profit growth."
What to do with a filing like this
Hindustan Unilever Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Hindustan Unilever Limited. Read the original for the full detail.